FDA Inspection
Gland Pharma Limited, Units I+II Pashamylaram SiteFDA Inspection 1043371 - Gland Pharma Limited, Units I+II Pashamylaram Site - February 23, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Gland Pharma Limited, Units I+II Pashamylaram Site, with an inspection on February 23, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 23, 2018
- Product Type
- Drugs
Open in Dashboard
ID · 2a89c877-04b5-44c9-bda9-2d69a6bcbb57
Violation Codes4
21 CFR 211.110(b)21 CFR 211.113(b)21 CFR 211.198(a)21 CFR 211.25(a)
Full citation text and observation details available on the Dashboard.